Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase III trial of MicroStat

Trial Profile

A Phase III trial of MicroStat

Planning
Phase of Trial: Phase III

Latest Information Update: 13 Nov 2018

At a glance

  • Drugs Phenylephrine/tropicamide (Primary)
  • Indications Mydriasis
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Nov 2018 Accoding to an Eyenovia media release,U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application, and this trial is expected to begin in late November.
    • 31 Aug 2018 New trial record
    • 14 Aug 2018 Accoding to an Eyenovia media release, the company is planning to initiate the trial in H2 2018 and report results in H1 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top